getting per patient updates is not statistically or clinically meaningful. It would be useless to look at an individual patient response and that’s why you need to wait for the readouts.
perhaps consider it another way. would you consider the release of one, two or three consecutive CR a clinical success yet, the subsequent patients 5, 10, 25, 100 show zero response?
I will stick with Berry consultants guidance that they need 50% death to determine any meaningful survival benefits.
Ann: OLE Study update reveals impressive Survival Data, page-237
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 17.0¢ | $32.95K | 193.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 280238 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 79436 | 2 |
View Market Depth
| Last trade - 10.45am 17/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |